Trial Profile
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in Middle-to-late Stages of Chronic Kidney Disease Patients: a Multi-center Randomized Controlled Study
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Benzbromarone (Primary) ; Febuxostat (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 02 Nov 2016 New trial record